Streetbeat News

Stock Prices

JNJ

Financial analysts have observed significant bullish activity in Johnson & Johnson (NYSE:JNJ) options, with 75% of trades being bullish. The options activity suggests a target price range of $120 to $165. Recent options trades include both bullish puts and bearish calls, with notable trades aiming for strike prices of $150 and $165. Johnson & Johnson, a leading healthcare firm, has seen its stock price increase by 0.4% to $160.48, with analysts setting an average price target of $203.67. The company is approaching its next earnings release in 42 days, amidst indications of being potentially overbought.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 6:17 pm

OXY

Occidental Petroleum (NYSE:OXY) has seen a mix of bullish and bearish options trading activity, with a slight lean towards bearish sentiment. The trading range for the stock is targeted between $55.0 and $67.0 over the next three months. The company's performance shows a slight decrease in stock price to $60.36 with a high trading volume and potential overbought RSI values. Analysts have mixed opinions, with an average target price of $71.0, varying from $62 to $77. Options trading suggests a cautious but potentially profitable approach for investors.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 6:17 pm

ROKU

Financial analysis of Roku's (NASDAQ:ROKU) options trading reveals a bearish sentiment among investors, with 61% showing bearish tendencies and 38% bullish. Significant trading activity predicts a price range of $55.0 to $85.0 for Roku in the next three months. The analysis includes details on unusual trades, volume, and open interest development, highlighting specific significant trades. Roku, a leading streaming platform, has seen a slight decrease in its stock price to $62.31, with potential oversold conditions indicated by RSI indicators. An earnings announcement is expected in 50 days.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 6:17 pm

VMEO

Vimeo shares have resumed trading.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 6:14 pm

AISP

AVAV

QNRX

SBFM

SOPH

SOPHiA GENETICS shares fell by 19% after reporting Q4 earnings below expectations and issuing weak 2024 guidance. Other stocks showed significant movement, with Sunshine Biopharma, Airship AI Holdings, and AeroVironment among the top gainers, while Quoin Pharmaceuticals, Crawford & Company, and Ekso Bionics led the losers.

Portfolio Pulse from Avi Kapoor

March 05, 2024 | 6:11 pm

AS

Amer Sports, Inc. (NYSE:AS) shares fell after reporting Q4 adjusted EPS results below expectations and issuing FY24 EPS guidance under estimates. Despite a 10% Y/Y revenue increase to $1.315 billion, surpassing consensus, and growth across several regions and segments, the adjusted EPS loss of $(0.11) missed the expected $0.01. The company forecasts a modest revenue growth of 6%-8% for Q1 FY24 and expects EPS of $(0.01)-$0.02, including negative impacts from non-recurring finance costs. For FY24, EPS is projected at $0.30-$0.40, below the consensus of $0.51.

Portfolio Pulse from Lekha Gupta

March 05, 2024 | 6:11 pm

MS

Elon Musk's $44 billion acquisition of X (formerly Twitter) involved financing from personal funds, Tesla stock sales, and contributions from investors like Fidelity, Ark Invest, Baron Funds, and Jack Dorsey. Banks, led by Morgan Stanley (NYSE:MS), are seeking to refinance about $12.5 billion in debt from the deal. Morgan Stanley, which covered a quarter of the debt, reported $876 million in losses from corporate loans in 2022. The banks have agreed not to sell their debt until X is financially stable. Fidelity has adjusted X's valuation, currently at $14.1 billion, amidst a boycott and potential for additional capital raising by Musk.

Portfolio Pulse from Chris Katje

March 05, 2024 | 6:10 pm

VMEO

Vimeo shares were halted due to a circuit breaker, indicating a significant move in the stock price that triggered trading pauses.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 6:10 pm

SMRT

SmartRent (NYSE:SMRT) shares fell after reporting Q4 earnings below expectations and providing weak revenue guidance for Q1 and FY24. Despite a 49% Y/Y revenue increase to $60.25 million and a positive adjusted EBITDA of $0.7 million, EPS of $(0.02) missed estimates. The company also announced a $50 million stock repurchase program but projected lower-than-expected revenue for the upcoming periods.

Portfolio Pulse from Lekha Gupta

March 05, 2024 | 6:07 pm

ADBE

Financial giants have shown a bearish trend on Adobe (NASDAQ:ADBE) through options trading, with 58% of trades being bearish. The analysis revealed 68 unusual trades, with puts valued at $3,043,098 and calls at $1,125,623. Whales target a price range of $400.0 to $700.0 for Adobe. The most significant trades include both bullish and bearish sentiments, with strike prices ranging from $540.00 to $660.00. Adobe's current stock price is down by -3.58%, trading at $547.59, with an anticipated earnings release in 9 days.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 6:03 pm